Literature DB >> 20427956

Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI).

Claudio Ronco, Peter A McCullough, Stefan D Anker, Inder Anand, Nadia Aspromonte, Sean M Bagshaw, Rinaldo Bellomo, Tomas Berl, Ilona Bobek, Dinna N Cruz, Luciano Daliento, Andrew Davenport, Mikko Haapio, Hans Hillege, Andrew House, Nevin M Katz, Alan Maisel, Sunil Mankad, Pierluigi Zanco, Alexandre Mebazaa, Alberto Palazzuoli, Federico Ronco, Andrew Shaw, Geoff Sheinfeld, Sachin Soni, Giorgio Vescovo, Nereo Zamperetti, Piotr Ponikowski.   

Abstract

The cardiorenal syndrome (CRS) is a disorder of the heart and kidneys whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction of the other. The general definition has been expanded into five subtypes reflecting the primacy of organ dysfunction and the time-frame of the syndrome: CRS type 1 = acute worsening of heart function leading to kidney injury and/or dysfunction; CRS type 2 = chronic abnormalities in heart function leading to kidney injury or dysfunction; CRS type 3 = acute worsening of kidney function leading to heart injury and/or dysfunction; CRS type 4 = chronic kidney disease leading to heart injury, disease and/or dysfunction, and CRS type 5 = systemic conditions leading to simultaneous injury and/or dysfunction of heart and kidney. Different pathophysiological mechanisms are involved in the combined dysfunction of heart and kidney in these five types of the syndrome. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20427956     DOI: 10.1159/000313745

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  28 in total

1.  Management of the cardiorenal syndrome in acute heart failure.

Authors:  Valentina Lazzarini; G Michael Felker
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

2.  Urinary Angiotensinogen Level Predicts AKI in Acute Decompensated Heart Failure: A Prospective, Two-Stage Study.

Authors:  Xiaobing Yang; Chunbo Chen; Jianwei Tian; Yan Zha; Yuqin Xiong; Zhaolin Sun; Pingyan Chen; Jun Li; Tiecheng Yang; Changsheng Ma; Huafeng Liu; Xiaobin Wang; Fan Fan Hou
Journal:  J Am Soc Nephrol       Date:  2015-02-26       Impact factor: 10.121

Review 3.  Current and future role of ultrafiltration in CRS.

Authors:  Claudio Ronco; Pierpaolo Giomarelli
Journal:  Heart Fail Rev       Date:  2011-11       Impact factor: 4.214

4.  Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study.

Authors:  Mahboob Rahman; Dawei Xie; Harold I Feldman; Alan S Go; Jiang He; John W Kusek; James Lash; Edgar R Miller; Akinlolu Ojo; Qiang Pan; Stephen L Seliger; Susan Steigerwalt; Ray R Townsend
Journal:  Am J Nephrol       Date:  2014-11-11       Impact factor: 3.754

Review 5.  Intravenous iron in heart failure: beyond targeting anemia.

Authors:  Donald S Silverberg; Adrian Iaina; Doron Schwartz; Dov Wexler
Journal:  Curr Heart Fail Rep       Date:  2011-03

6.  Impact of worsening renal function during the treatment of decompensated heart failure on changes in renal function during subsequent hospitalization.

Authors:  Jeffrey M Testani; Thomas P Cappola; Brian D McCauley; Jennifer Chen; James Shen; Richard P Shannon; Stephen E Kimmel
Journal:  Am Heart J       Date:  2011-05       Impact factor: 4.749

Review 7.  The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?

Authors:  Filippos Triposkiadis; Randall C Starling; Harisios Boudoulas; Gregory Giamouzis; Javed Butler
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 8.  Can we prevent or treat renal dysfunction in acute heart failure?

Authors:  Valentina Lazzarini; Luca Bettari; Silvia Bugatti; Valentina Carubelli; Carlo Lombardi; Marco Metra; Livio Dei Cas
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

9.  Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction.

Authors:  Jeffrey M Testani; Stephen E Kimmel; Daniel L Dries; Steven G Coca
Journal:  Circ Heart Fail       Date:  2011-09-08       Impact factor: 8.790

10.  The Role of Congestion in Cardiorenal Syndrome Type 2: New Pathophysiological Insights into an Experimental Model of Heart Failure.

Authors:  Annalisa Angelini; Chiara Castellani; Grazia Maria Virzì; Marny Fedrigo; Gaetano Thiene; Marialuisa Valente; Claudio Ronco; Giorgio Vescovo
Journal:  Cardiorenal Med       Date:  2015-10-31       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.